14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.70 $93.35 Wednesday, 24th Apr 2024 BMRN stock ended at $91.20. This is 0.93% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.20% from a day low at $91.01 to a day high of $93.02.
90 days $83.44 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Jun 01, 2023 $87.16 $88.44 $85.66 $88.26 1 038 979
May 31, 2023 $87.54 $88.50 $86.58 $86.94 1 847 004
May 30, 2023 $88.20 $88.45 $86.40 $87.22 1 041 232
May 26, 2023 $88.89 $89.81 $88.48 $88.49 711 493
May 25, 2023 $89.95 $89.95 $87.81 $88.73 941 504
May 24, 2023 $91.76 $91.80 $90.38 $90.54 658 324
May 23, 2023 $92.43 $93.27 $91.64 $91.99 732 694
May 22, 2023 $92.04 $93.11 $91.80 $92.77 591 091
May 19, 2023 $92.53 $93.35 $91.53 $91.90 766 254
May 18, 2023 $92.48 $92.48 $91.16 $92.23 622 183
May 17, 2023 $92.52 $92.75 $91.41 $92.27 825 166
May 16, 2023 $93.61 $94.41 $90.99 $92.02 1 204 524
May 15, 2023 $94.04 $96.47 $93.93 $95.18 973 401
May 12, 2023 $96.05 $96.16 $93.37 $93.93 1 054 201
May 11, 2023 $95.15 $95.40 $93.94 $95.39 806 393
May 10, 2023 $96.02 $96.02 $93.94 $95.14 773 250
May 09, 2023 $95.49 $95.98 $93.80 $95.61 835 998
May 08, 2023 $96.69 $96.74 $95.08 $95.94 771 256
May 05, 2023 $95.79 $97.13 $94.84 $96.63 913 075
May 04, 2023 $93.89 $95.47 $92.30 $95.45 791 491
May 03, 2023 $93.64 $94.50 $93.04 $93.58 960 951
May 02, 2023 $96.29 $96.77 $93.62 $93.82 1 039 942
May 01, 2023 $96.54 $97.42 $95.30 $96.98 1 027 387
Apr 28, 2023 $92.07 $96.55 $91.96 $96.04 1 703 077
Apr 27, 2023 $92.07 $93.40 $89.25 $92.45 1 941 038
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT